Chongqing Di-Link Pharmaceutical Co.Ltd

Company Description

Chongqing Di-Link Pharmaceutical Co., Ltd, one subsidiary of Zen, is a modern pharmaceutical factory, which mainly deals with APIs & Intermediates manufacture. Chongqing Di-Link Pharmaceutical Co.Ltd possess advanced technology and equipments, owns GMP management systems of production & quality, and has mature Environmental, Health and Safety (EHS) facilities. The existing staffs in Di-Link are rich experienced in chemical synthesis, API production, and quality control and assurance. Our main products, Orlistat and Voglibose have absolute competitive advantages in process, specifications, and quality control. Based on the scientific support of the R&D Centre, Di-Link has got the strong innovation and development ability specialized in API & Intermediates. We are taking "Survival of Quality, Benefit of Management, and Brand of Honest" as our principle, and striving to grow up as an international pharmaceutical company.

Company Information

  • Telephone:
  • Business Type:Exporters
  • Year Established:2001
  • Number Of Employees:100+
  • Trade Capacity:Export Percentage:
  • Main Products:Orlistat,Nizatidine, Cilostazol,Voglibose,Tropisetron Hydrochloride
  • Address:Other, China
  • Main Markets:Americas,Africa,Asia,Europe,Worldwide
Countries   China   India   Indonesia   Malaysia   Pakistan   Turkey   United Kingdom   United States   All Countries